Introduction
Research has been conducted around the world to assess the occurrence and impact of Common Mental Disorders (CMD). The concept of CMDs characterizes cases that present non-psychotic symptoms, such as insomnia, fatigue, nervousness, headaches, depressive symptoms, irritability, forgetfulness, difficulty concentrating, and non-specific symptoms that lead to functional incapacity but do not meet the requirements of diagnoses listed in the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV) (1) .
Nonetheless, the fact these conditions do not fit established diagnostic categories does not relieve the distress of patients, while unnecessary costs increase with referrals and exams, since most professionals usually focus only on the immediate complaint (2) . It is also believed that CMDs can lead to high social, economic and individual costs, since such disorders account for one third of the days missed at work and one fifth of all PHC appointments (2) .
Among the facts related to the occurrence of CMDs are those associated with worse socioeconomic conditions in many countries (3) , including Brazil.
Brazilian studies highlight low education, being a female, marital status of being separated or widowed, low income, unemployment, and low social status, living in regions of great socioeconomic inequality, and stress-producing events (2) .
Research addressing CMDs in Brazil reveals prevalent rates that vary from 17% to 35% (4) , and even reach 50% (5) . In addition to a high prevalence in the population and the potential costs related to CMDs, some studies also report an association between CMDs and the use of medication and chronic comorbidities, such as high blood pressure, diabetes, and thyroid diseases (4, 6) .
Even more relevant, a study shows association between CMDs with polypharmacy (7) . Hence, the importance of studies characterizing the pharmacotherapy profile of these patients is apparent, seeking their own safety since the concomitant use of various medications may lead to drug interactions and a higher rate of side effects, thus compromising patients' health (6) .
Another measure that can support the characterization of aspects related to patient safety concerning the use of medications is medication adherence. In this sense, the literature has shown that the non-adherence of patients with chronic conditions, such as potential comorbidities associated with CMDs, may reach 75%. The reasons for such high levels of medication non-adherence might be related to a lack of understanding on the part of patients that adherence may influence their quality of life and independence in the future (8) . It is known that the quantity of pills taken daily may interfere in adherence due to a greater chance of side effects. A study revealed that the risk of nonadherence increases 12% for each pill taken (9) .
Such studies, however, did not investigate the relationship between these variables and CMDs. 
. The validated Brazilian version of the SRQ-20 (Self-Reporting Questionnaire) was used to identify the prevalence of CMDs (11) . The SRQ-20 is a dichotomous scale composed of 20 questions in which each affirmative answer scores one and comprises the total score. Individuals who answer "yes" to eight or more questions are considered to test positive for CMDs (11) (12) .
Level of adherence was defined by the application of the Adherence Measure Test (AMT) (13) . This test is composed of seven questions. The first is "Have you ever forgotten to take medications?" A Likert scale from 1 to 6 is used for each question. A score of 1 corresponds to "always" (indicating low adherence) and a score of 6 corresponds to "never" (indicating high adherence). The score of each answer is totaled and then divided by the number of questions. Those patients who scored from 1 to 4 on the AMT, that is, checked the answers "always", "almost always", "frequently", and "sometimes," were considered to be non-adherent, while those who scored 5 and 6, which indicate answers "rarely" and "never," respectively, were considered to be adherent.
A qualitative approach was used in the data analysis.
Data were analyzed using the Statistical Package for the Social Sciences (SPSS, version 17.0). Statistical associations were found between the study's variables using Fisher's exact test, while the hypothesis of association was accepted when p was equal or below 0.05.
Results

Characterization of the study's participants and Common Mental Disorders
Participants were 106 users of a PHC unit in the interior of São Paulo, Brazil. The sample was mainly composed of women (88.7%) while the average age of patients was 40 years old, ranging from 18 to 68
years old. Table 1 shows that half of the interviewed patients (50%) tested positive for CMDs. CMDs were associated with the variables occupation (p<0.01) and family income (p=0.05). The prevalence of CMDs was greater among unemployed (64.7%) and retired (85.7%) individuals. There was also a trend for CMDs to be associated with level of education (p=0.06). 
Pharmacotherapy Profile and Common Mental
Disorders
In regard to the medications used by the participants ( Table 2 ) that are listed in the Anatomical Therapeutic Chemical Classification System (ATC)
adopted by the World Health Organization, the following are usually used for high blood pressure and were present in 25% of the prescriptions: C09 (Agent acting on the renin-angiotensin system), C03 (Diuretics) and C07A (Beta blocking agents). We note that 12.9%
of the prescriptions were in the N06A classification 
Medication adherence
In regard to medication adherence, the number of patients who responded to the AMT (48) is greater than the number of patients considered to have used the medications previously described (43). Such a difference is due to the fact that five patients reported the use of ongoing medications and for this reason they answered the AMT. However, their medical files did not list any medications and we opted to use data from the medical files instead in order to minimize errors.
Therefore, 27.1% of the patients were considered to be non-adherent to medication according to the AMT. Additionally, in regard to the number of types of medications, we observed that patients with more than three types of prescribed medications had a higher percentage of adherence (76.2%) when compared to those who had up to two types of medications prescribed (54.5%). The same occurred with the number of pills taken a day: greater adherence (78.6%) was observed among patients taking three or more pills a day, when compared to patients taking up to two pills a day (40%). Such differences, however, were not found to be significant according to Fisher's test (p=0.99).
The statistical analysis did not show any association between CMDs and medication adherence (p=0.52).
Nonetheless, 69% of the patients who tested positive for
CMDs adhered to their medication, while this percentage was higher (78.9%) among those who tested negative for CMDs.
Discussion
Analysis of the patients' socio-demographic profiles revealed that most individuals were female. One of the inclusion criteria was having a medical appointment (5, (14) (15) . Even though there is evidence of a social and biological predisposition in women, given the neuroendocrinological system and social roles, which together increase their susceptibility to these disorders, the potential explanations for an association with sex have yet to be clarified (16) . In agreement with this study's findings, there are studies
showing no association between sex and CMDs (2, 4) .
These studies' authors do not explain such findings and suggest that further studies are needed to better understand the relationships between these variables.
As this study shows an association between
CMDs and the socio-demographic variables occupation and family income, other studies have attributed the high prevalence of CMDs to indicators that show social disadvantage (15, 17) . In relation to the association between CMDs and occupation, the literature reveals that unstable labor contracts, low salaries, and a lack of social benefits and labor-rights protection lead to anxiety and depression among informal workers and unemployed individuals (14, 17) . Obviously, the work situation of individuals influences family income and informal workers or unemployed individuals with a lower family income are more subject to CMDs (14) . Such consequently, harm one's psychological health (2, 14) .
Given the knowledge that a socio-demographic profile that indicates social disadvantage is strongly associated with CMDs in the scope of PHC, which is the object of this study, there is a need for strategies and to train professionals who provide care to this population.
The current Brazilian Mental Health Policy provides the inclusion of mental health actions in this scope. It also suggests the implementation of some of these actions, such as Matrix Support. However, such actions are absent in most of these services, despite the high prevalence of CMDs reported in the literature (4) (5) and in this study. The professionals' lack of training is an obstacle because, in addition to many professionals being incapable of detecting signs of mental disorders, they do not believe that mental health is a responsibility of PHC (18) (19) . In this context, PHC nurses play an important role in adapting mental health actions to patients who present social disadvantage since these professionals know the realities of patients and can facilitate the supply of integral care.
Considering the study's objectives and its relevance for clinical practice, the fact that half of the interviewed patients have presented CMDs draws attention. Even though this percentage is in agreement with the literature showing that the world prevalence of CMDs ranges from 22.7% to 50.3% (4) (5) (6) 17, 20) , it is a concern given its considerable impact on care provided within the scope of PHC. In agreement with the literature, this study's results reveal an association between CMDs and the use of psychotropic medications. The rate of use of psychotropic medications observed in this study (12.9%) was similar to that observed in the population in general, which is estimated to be from 9% to 13% (15) . If, however, we consider the number of patients who tested positive for CMDs, we can infer that a large number of them do not receive mental health treatment, even though they need such treatment. These aspects show the need to devise new strategies to approach this issue in the health services, considering the representations of the disease in specific groups, which may be different from those that ground the knowledge of modern physicians, which is focused on the mind and body dichotomy, and value both attentive listening and properly receiving patients within the health system (1, 19, 21) .
We note that the symptomatology presented by these patients are frequently identified by the health system as symptomatic of distress, in agreement with the current biological model, in which it is more acceptable that people complain of organic diseases or physiological alterations, because these are more "objective" (21) . As a consequence, because these patients do not have their complaints properly addressed, they may return to the service many times, overloading the system and increasing costs with unnecessary exams and medication.
The findings concerning the use of medication corroborate this conclusion since data concerning the patients' pharmacotherapy profile show an association between CMDs and the use of medication, the number of prescribed medications and the number of pills taken daily. The percentage of patients who use more than two Gomes VF, Miguel TLB, Miasso AI.
types of medications a day and more than two pills a day is greater among those who tested positive for CMDs, which is in agreement with a previous study that also found associations between CMDs and polypharmacotherapy (4) . This is a concern since polypharmacotherapy poses severe health risks as it increases the chances of drug interactions and side effects.
The association between CMDs and the use of medication was also found in a study in which individuals with CMDs were twice as likely to use medication when compared to individuals without CMDs. This same study also revealed an association between CMDs and clinical comorbidities. Even though that variable was not investigated in this study, a high number of medications were prescribed for organic pathologies. According to the ATC classification shown in Table 2 , the most prevalent class of medication was that for blood pressure followed by medications for peptic ulcers and diabetes.
In relation to medication adherence, we found that 27.1% of the patients were identified as nonadherent. Considering the types of the most prescribed medications in this study, we observe that the rate of adherence found is in agreement with the literature, in which adherence to diabetes and high blood pressure medication ranges from 36% to 66% (22) (23) .
Although statistical association between CMDs and therapy adherence has not been shown, a lower level of adherence was observed among those with CMDs.
As previously mentioned, it is known that the number of medications, along with the number of pills, taken daily interferes with therapy adherence (9, 15) . In this regard, one study (24) revealed that the use of multiple medications exposes the patient to more complex treatment that requires more attention, memory and organization in order to deal with the times the medication are administered.
As observed in previous studies (5) (6) , this study's findings corroborate the idea that even though CMDs are prevalent, they are not identified by health professionals, the evidence for which is the large number of medications related to organic complaints prescribed to patients with CMDs.
We note that the issue is not about encouraging the discussion of the issues of collective interest (1) .
There is evidence that health technologies, such as the use of telephones, can strengthen bonds between professionals and patients, as well as encourage therapy adherence (25) . Another strategy is the supply of group care using techniques such as psychoeducation or group therapy (26) .
Since studies on this topic indicate that there is a strong relationship between CMDs and psychosocial issues, as opposed to the professionals' attitude of being prone to medicate; the actions of health professionals should take into account the cultural codes of individuals cared for in PHC, who are usually labeled as "polycomplainers", "psychosomatic" or "hysterical" (1) . In addition to the challenge of properly addressing these patients, the competence and technical qualification of professionals should be taken into account since PHC units are staffed with general medical practitioners, which may hinder the identification of CMDs (2) .
Because this is a cross-sectional study, causal relationships cannot be established among the observed associations. However, the theory of stressproducing events and the theory of social roles and social support have been established for years as explanations for socioeconomic indicators and CMDs (27) .
Another limitation of this study is the use of a screening instrument to establish the prevalence of CMDs instead of the gold standard of psychiatric interviews. Such a potential drawback, however, is resolved by validation studies that compare the instrument to the gold standard, confirming the cut off point adopted in this study (12) .
Conclusions
The association of CMDs with socioeconomic variables reaffirms the view that the presence of these disorders is strongly linked to social disadvantage. Also, the results of this study reveal a sample of patients with a high prevalence of CMDs and a high level of use of medication and also the unsafe use of medications,
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given the association of CMDs and pharmacotherapy variables with lower therapy adherence among patients with CMDs.
We note that a large part of the medications prescribed are for organic diseases, thus patients do not receive care appropriate to their profiles, which also include complaints of a psychological order.
From this perspective, this study's results show the importance of health professionals working in PHC being prepared to detect psychological complaints among the population to which they provide care. It is also necessary to reflect upon the education of health professional in the psychiatric field who are usually found only in specialized services, which may hinder the adoption of the biopsychosocial health concept in clinical practice.
Further research, especially population-based longitudinal studies, is needed to better understand the associations found and provide insights that strengthen mental health care within the PHC sphere.
